Clinical Trial Update: SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of SAR 1118 in patients undergoing pars plana vitrectomy for diabetic macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• SAR 1118

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetic Macular Edema (DME), Pars Plana Vitrectomy | Phase 1 | Status: TERMINATED